Top Clinical Trials Stories


Comment & Analysis »

GlobalData Healthcare

Can DAA treatment increase the risk of HCC? Emerging data points towards ‘no’

Direct-acting-antivirals (DAA) can cure patients of the life-threating hepatitis C virus (HCV) infection, with cure rates exceeding 95%. However, questions have been raised about the...

Can DAA treatment increase the risk of HCC? Emerging data points towards ‘no’
GlobalData Healthcare

How your gut microbiome can interfere with cancer treatment and how to avoid it

How your gut microbiome can interfere with cancer treatment and how to avoid it
GlobalData Healthcare

Highlights from the 2017 ATS Conference: positive results for AstraZeneca’s Daliresp beyond reducing the risk of exacerbations

Highlights from the 2017 ATS Conference: positive results for AstraZeneca’s Daliresp beyond reducing the risk of exacerbations
GlobalData Healthcare

Eiger Bio’s PAH drug Ubenimex moves one step closer to fulfilling an unmet need

Eiger Bio’s PAH drug Ubenimex moves one step closer to fulfilling an unmet need
Elly Earls

Micro-machines: nanotech offers new possibilities for disease detection and drug delivery

Micro-machines: nanotech offers new possibilities for disease detection and drug delivery

Company Releases »

Rules for Investigating Good Manufacturing Practice (GMP) Deviations in Sterile Processing

NSF Health Sciences, Pharma Biotech
Rules for Investigating Good Manufacturing Practice (GMP) Deviations in Sterile Processing

Applications in Pharmaceutical Manufacturing

Alconox Applications in Pharmaceutical Manufacturing

Preclinical Immunology for Vaccine and Immunotherapy Development

PAIRimmune
Preclinical Immunology for Vaccine and Immunotherapy Development

Contract Research Organisation for Early Development of First-in-Human Oncology Clinical Trials

Ce3 Contract Research Organisation for Early Development of First-in-Human Oncology Clinical Trials

Clinical Trials Insights »

Companies »